Novel Pyrone-Based Biofilm Inhibitors against Azole-Resistant Candida albicans

Area of Science:

• Mycology
• Infectious Diseases
• Medicinal Chemistry

Background:

• Opportunistic fungal infections pose significant threats to immunocompromised individuals, particularly those with HIV and cancer.
• Biofilm formation by this common fungal species on medical devices and human tissue contributes to persistent and difficult-to-treat infections.
• Hyphal development, driven by proteins like HWP and ALS, is crucial for fungal biofilm establishment.

Purpose of the Study:

• To design and synthesize novel alpha-pyrone analogues.
• To evaluate the potential of these compounds in inhibiting fungal biofilm formation and hyphal development.
• To identify promising candidates for managing drug-resistant fungal strains.

Main Methods:

• Synthesis of novel alpha-pyrone-based compounds.
• Assessment of biofilm inhibition and hyphal development in vitro.
• Dose-dependent evaluation of compound efficacy.
• Testing for effects on planktonic cell growth.

Main Results:

• Three synthesized compounds (6f, 6j, and 6n) demonstrated significant inhibition of biofilm formation.
• These compounds dose-dependently reduced cell aggregation and hyphal formation.
• Minimal impact on planktonic cell growth was observed at effective biofilm inhibitory concentrations (20-50 μg/mL).

Conclusions:

• Novel alpha-pyrone analogues show potent antifungal activity against biofilm formation.
• Compounds 6f, 6j, and 6n are promising candidates for managing drug-resistant fungal infections.
• These compounds may offer synergistic therapeutic potential when used with existing antifungal agents.